May 12, 2022 / 12:00PM GMT
Operator
Greetings, and welcome to the Chemomab first quarter 2022 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.
I'd now like to turn the conference over to your host, Barbara Lindheim, Consulting Vice President, Strategic Communications for Chemomab. Thank you. You may begin.
Barbara Lindheim - Chemomab Therapeutics, Ltd. - Consulting VP, Strategic Communications
Welcome to the Chemomab Therapeutics 2022 first-quarter conference call. Thank you for attending. I am Barbara Lindheim, Consulting Vice President of Strategic Communications at Chemomab.
With me today are Dale Pfost, our Chairman and CEO; Don Marvin, CFO, Chief Operating Officer, and Executive Vice President; Dr. David Weiner, Interim CMO; and Dr. Adi Mor, our Co-Founder and Chief Scientific Officer.
Before turning the call over to Dale, please take note of our forward-looking statements. Today's call may contain forward-looking statements, which may be identified by words such as may, could, will, expect, intend, planned, and other
Q1 2022 Chemomab Therapeutics Ltd Earnings Call Transcript
May 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers